Actively Recruiting
Real World Evaluation of Lifelight®: A Contactless Vital Signs Monitor for Self-monitoring Blood Pressure and Its Comparison to Standard of Care
Led by Xim Limited · Updated on 2025-04-03
500
Participants Needed
1
Research Sites
46 weeks
Total Duration
On this page
Sponsors
X
Xim Limited
Lead Sponsor
B
Barts & The London NHS Trust
Collaborating Sponsor
AI-Summary
What this Trial Is About
A randomised controlled trial for comparison of real-world feasibility and clinical outcomes of two different methods of home blood pressure monitoring Participants aged 18 years or over with diagnosed and treated hypertension (including via lifestyle interventions) that is not controlled (i.e. in-clinic measurement is 140/90 mmHg or greater) will be recruited from hypertension hospital clinics
CONDITIONS
Official Title
Real World Evaluation of Lifelight®: A Contactless Vital Signs Monitor for Self-monitoring Blood Pressure and Its Comparison to Standard of Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Established diagnosis of hypertension
- Uncontrolled hypertension defined as office blood pressure 140/90 mmHg
- Stable hypertension medication for at least 4 weeks if pharmacologically treated
- Ability to read, write, and understand English
- Capacity to give informed consent
- Access to a compatible device for Lifelight4 or provided device by xim Ltd.
You will not qualify if you...
- Stage III hypertension with office blood pressure 180/120 mmHg or deemed unsafe by investigators
- Diagnosed atrial fibrillation
- Significant arrhythmias affecting blood pressure or poor perfusion
- Pregnancy or pre-eclampsia
- Physical deformities or skin disorders preventing proper blood pressure cuff use
- Unwillingness or incapacity to perform self-monitoring
- Partners or spouses of participants already in the trial
- Patients on dialysis or with end-stage kidney disease
- Patients receiving active cancer treatment
- Terminal illness
- Inability to sit for up to one hour
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
William Harvey Heart Centre, Queen Mary Queen Mary University of London, Charterhouse Square,
London, United Kingdom, EC1M 6BQ
Actively Recruiting
Research Team
L
Laurence Pearce, BSc, MBA
CONTACT
G
Gauri Misra, BDS, MSc.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here